Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Haleon PLC Sponsored ADR (HLN)
NYSE:HLN
RESEARCH TOOLSreports
Holding HLN?
Track your performance easily
Earnings Data
Report Date
Feb 27, 2025Before Open Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
$0.11Last Year’s EPS
$0.14Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Aug 01, 2024
|% Change Since: 6.47%
|Next Earnings Date:Feb 27, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mix of strong growth in several segments and successful product launches, balanced by challenges in North America and China, and margin pressures in the U.S. Despite these challenges, the company expressed confidence in its guidance and strategic initiatives.Company Guidance
During the Haleon Q2 2024 earnings call, guidance was provided indicating a robust outlook for the second half of the year, with expectations for organic sales growth towards the upper end of the 4% to 6% range, implying a 5% to 9% increase in the second half. The company highlighted strong performance in North America despite a slight decline due to inventory adjustments, with expectations of improved net sales growth as these factors stabilize. The launch of new products, such as the erectile dysfunction OTC cream, is anticipated to contribute positively, although its impact is expected to be more pronounced in future periods. The company also emphasized continued investment in key growth areas like Oral Health and VMS, with an increased A&P spend planned for the latter half of the year. Overall, Haleon remains confident in their upgraded profit guidance, projecting high single-digit growth for the full year, driven by effective pricing strategies, easing cost inflation, and ongoing efficiencies.Strong Organic Sales Growth
Haleon reported that a significant portion of their turnover is growing in excess of 8% in the first half of the year, with expectations for the second half to potentially reach the top end of their 4% to 6% growth range.
Successful Product Launches
The company highlighted strong performances from new product launches, particularly in the Oral Health and VMS (Centrum) segments, driven by scientific claims and geographic expansion.
Share Buyback Program
Haleon continued with its $500 million share buyback program and introduced open market purchases, adding flexibility to its capital return strategy.
Cost Management and Margin Improvement
Gross margin expanded by 150 basis points in H1, driven by pricing, easing inflation, and efficiency improvements.
---
HLN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HLN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 01, 2024 | $9.10 | $9.28 | +1.98% |
| Feb 29, 2024 | $7.92 | $8.41 | +6.19% |
| Aug 02, 2023 | $8.36 | $8.13 | -2.75% |
| Mar 02, 2023 | $7.68 | $7.40 | -3.65% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Haleon PLC Sponsored ADR (HLN) report earnings?
Haleon PLC Sponsored ADR (HLN) is schdueled to report earning on Feb 27, 2025, Before Open Not Confirmed.
What is Haleon PLC Sponsored ADR (HLN) earnings time?
Haleon PLC Sponsored ADR (HLN) earnings time is at Feb 27, 2025, Before Open Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HLN EPS forecast?
HLN EPS forecast for the fiscal quarter 2024 (Q4) is $0.11.
---